Label: VALMONT DAILY VEIL. MOISTURIZING FACE FLUID MINERAL SUNSCREEN- zinc oxide cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated October 18, 2023

If you are a consumer or patient please visit this version.

  • Active Ingredient

    Zinc Oxide 17.5%

  • Purpose

    Sunscreen

  • Uses

    • Helps prevent sunburn.
    • If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.
  • Warnings

    For External use only.

  • Do not use

    • on damaged or broken skin.
  • When using this product

    • keep out of eyes. Rinse with water to remove.
  • Stop use and ask a doctor if

    • rash occurs.
  • Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • apply liberally 15 minutes before sun exposure.
    • reapply at least every 2 hours.
    • use a water-resistant sunscreen if swimming or sweating.
  • Sun Protection Measures:

    • Spending time in the sun increases your risk of skin cancer and early skin aging.  To decrease this risk, regularly use a sunscreen with broad spectrum SPF value of 15 or higher and other sun protection measures including:
    •    limit time in the sun, especially from 10 a.m. - 2 p.m.
    •    wear long-sleeve shirts, pants, hats and sunglasses.
    •    children under 6 months of age: Ask a doctor 
  • Other Information

    Protect the product in this container from excessive heat and direct sunlight.

  • Inactive Ingredients

    C15-19 alkane, hydrogenated polydecene, squalane, water, caprylic/capric triglyceride, silica, octyldodecanol, synthetic fluorphlogopite, propanediol, ethylene/propylene/styrene copolymer, isoamyl laurate, disteardimonium hectorite, polyhydroxystearic acid, argania spinosa kernel oil, methylsilanol mannuronate, polyglyceryl-2 oleate, tocopheryl acetate, silanediol salicylate, propylene carbonate, fragrance, ethylhexylglycerin, lecithin, isostearic acid, polyglyceryl-3 polyricinoleate, polyglyceryl-2 stearate, tocopherol, butylene/ethylene/styrene copolymer, urea, glycerin, bisabolol, potassium sorbate, pentaerythirtyl tetra-di-t-butyl hydroxyhdrocinnamate, phenoxyethanol, RNA, decarboxy carnosine HCL, butylene glycol, pentylene glycol, sodium acetylated hyaluronate, sodium hyaluronate, sodium hyaluronate crosspolymer, hydrolyzed sodium hyaluronate

  • Questions or Comments

    1-866-411-8256

  • Valmont Daily Veil Moisturizing Face Sunscreen 73248-508-00

    Label for Carton Valmont Daily Veil

  • INGREDIENTS AND APPEARANCE
    VALMONT DAILY VEIL. MOISTURIZING FACE FLUID MINERAL SUNSCREEN 
    zinc oxide cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73284-508
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC CATION - UNII:13S1S8SF37) ZINC CATION175 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    C15-19 ALKANE (UNII: CI87N1IM01)  
    HYDROGENATED POLYDECENE TYPE I (UNII: U333RI6EB7)  
    SQUALANE (UNII: GW89575KF9)  
    WATER (UNII: 059QF0KO0R)  
    MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    OCTYLDODECANOL (UNII: 461N1O614Y)  
    MAGNESIUM POTASSIUM ALUMINOSILICATE FLUORIDE (UNII: YK3DC63Y5M)  
    PROPANEDIOL (UNII: 5965N8W85T)  
    ISOAMYL LAURATE (UNII: M1SLX00M3M)  
    DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
    POLYHYDROXYSTEARIC ACID (2300 MW) (UNII: YXH47AOU0F)  
    ARGAN OIL (UNII: 4V59G5UW9X)  
    METHYLSILANOL ASCORBATE (UNII: 46Z5D1I0IS)  
    POLYGLYCERYL-2 OLEATE (UNII: 5759J47SAM)  
    .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    SILANEDIOL SALICYLATE (UNII: C054DF30K0)  
    PROPYLENE CARBONATE (UNII: 8D08K3S51E)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    ISOSTEARIC ACID (UNII: X33R8U0062)  
    POLYGLYCERYL-3 PENTARICINOLEATE (UNII: 7Q0OK5DOT4)  
    POLYGLYCERYL-2 STEARATE (UNII: 253MC0P0YV)  
    TOCOPHEROL (UNII: R0ZB2556P8)  
    UREA (UNII: 8W8T17847W)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    LEVOMENOL (UNII: 24WE03BX2T)  
    POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
    PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) (UNII: 255PIF62MS)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    RNA-BINDING MOTIF PROTEIN 39 (UNII: 7CGZ92983T)  
    DECARBOXY CARNOSINE HYDROCHLORIDE (UNII: 6X7K9I5QR7)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    PENTYLENE GLYCOL (UNII: 50C1307PZG)  
    SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93)  
    HYALURONIC ACID (UNII: S270N0TRQY)  
    HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
    SODIUM S-(2-HYDROXY-3-(3-(TRIHYDROXYSILYL)PROPOXY)PROPYL) SULFUROTHIOATE (UNII: 2V56GQW1BM)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:73284-508-001 in 1 CARTON01/07/2024
    130 mL in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02001/07/2024
    Labeler - Innovation Labs, Inc. (117109069)